Chelsea Leigh Hassig, FNP Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 3101 W Ridge Rd Bldg D, Greece, NY 14626 Phone: 585-225-1580 |
News Archive
A first-in-human study presented at the Society of Nuclear Medicine and Molecular Imaging 2020 Annual Meeting has demonstrated the safety, favorable pharmacokinetic and dosimetry profile of 64Cu-EBRGD, a new, relatively long-lived PET tracer, in patients with glioblastomas.
Some people call it "the dark time," the period between when a person is diagnosed with Parkinson's disease and when treatment with medication begins.
In the 15 minutes a primary care doctor typically has with a patient, she's expected to diagnose the current ailment, help manage ongoing health issues and provide preventive care. In this setting, confronting all but the most obvious and immediate mental health needs of patients is an ongoing challenge.
Genentech, Inc. and Roche have announced that the New England Journal of Medicine published the first Phase III study of an anti-angiogenesis cancer therapy, showing that the addition of Avastin™ (bevacizumab) to the IFL chemotherapy regimen (5-FU/Leucovorin/ CPT-11) significantly extended survival in patients with first-line (previously untreated) metastatic colorectal cancer.
› Verified 1 days ago